Ribozyme-mediated revision of RNA and DNA

Por Long, Meredith B., Jones, J.P., Sullenger, Bruce A., Byun, Jonghoe
Publicado em 2003

Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: Implications for identifying molybdopterin nitrite reductases

Por Weidert, E.R., Schoenborn, S.O., Cantu-Medellin, N., Choughule, K.V., Jones, J.P., Kelley, E.E.
Publicado no Nitric Oxide (2014)

Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder

Por Nasser, Azmi F., Greenwald, Mark K., Vince, Bradley, Fudala, Paul J., Twumasi-Ankrah, Philip, Liu, Yongzhen, Jones, JP, Heidbreder, Christian
Publicado no J Clin Psychopharmacol (2016)

Gated Regional Spirometry (GRS)

Por Touya, J.J., Price, R.R., Patton, J., Erickson, J.J., Jones, J.P., Goddard, J., Wolfe, O., Novak, G.R., Rollo, F.D., Brigham, K.L.
Publicado em 1978

ROLE OF CYTOCHROME P450 2C8 AND 2J2 GENOTYPE IN CALCINEURIN INHIBITOR INDUCED CHRONIC KIDNEY DISEASE

Por Smith, Helen E., Jones, JP., Kalhorn, Thomas F., Farin, Fredrico M., Stapleton, Patricia L., Davis, Connie L., Perkins, James D., Blough, David K., Hebert, Mary F., Thummel, Kenneth E., Totah, Rheem A.
Publicado em 2008